Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1997 1
2002 1
2004 1
2005 1
2006 2
2007 2
2008 2
2009 4
2010 3
2011 2
2012 5
2013 6
2014 4
2015 5
2016 3
2017 11
2018 9
2019 12
2020 15
2021 12
2022 10
2023 12
2024 14
2025 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Results by year

Filters applied: . Clear all
Page 1
Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.
Ruzicka T, Hanifin JM, Furue M, Pulka G, Mlynarczyk I, Wollenberg A, Galus R, Etoh T, Mihara R, Yoshida H, Stewart J, Kabashima K; XCIMA Study Group. Ruzicka T, et al. N Engl J Med. 2017 Mar 2;376(9):826-835. doi: 10.1056/NEJMoa1606490. N Engl J Med. 2017. PMID: 28249150 Free article. Clinical Trial.
Enoxaparin-induced eruptive angiokeratomas.
Niedźwiedź M, Żebrowska A, Lesiak A, Narbutt J, Skibińska M. Niedźwiedź M, et al. Among authors: zebrowska a. Pol Arch Intern Med. 2023 May 23;133(5):16463. doi: 10.20452/pamw.16463. Epub 2023 Mar 14. Pol Arch Intern Med. 2023. PMID: 36916492 Free article. No abstract available.
Tree Nut Allergy in Children-What Do We Know? -A Review.
Chudoba A, Żebrowska A, Sybilski AJ. Chudoba A, et al. Among authors: zebrowska a. Nutrients. 2024 Nov 21;16(23):3978. doi: 10.3390/nu16233978. Nutrients. 2024. PMID: 39683372 Free PMC article. Review.
A randomized phase III study to compare efficacy and safety of BAT2206 (proposed ustekinumab biosimilar) with reference ustekinumab in patients with moderate to severe plaque psoriasis.
Man X, Zaharieva K, Pulka G, Żebrowska A, Deng Y, Mekokishvili L, Yang X, Qi Y, Gu C, Dong Q, Zheng M. Man X, et al. Among authors: zebrowska a. J Am Acad Dermatol. 2025 Apr;92(4):724-731. doi: 10.1016/j.jaad.2024.10.104. Epub 2024 Nov 24. J Am Acad Dermatol. 2025. PMID: 39592058 Clinical Trial.
143 results